Logo image of ANZU

ANZU SPECIAL ACQUISITION -A (ANZU) Stock Fundamental Analysis

NASDAQ:ANZU - Nasdaq - US03737A1016 - Common Stock - Currency: USD

7.015  +1.38 (+24.38%)

After market: 7.02 +0 (+0.07%)

Fundamental Rating

0

ANZU gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. ANZU has a bad profitability rating. Also its financial health evaluation is rather negative. ANZU has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ANZU had positive earnings in the past year.
In the past year ANZU has reported a negative cash flow from operations.
ANZU Yearly Net Income VS EBIT VS OCF VS FCFANZU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 5M -5M 10M 15M

1.2 Ratios

Industry RankSector Rank
ROA 7.24%
ROE 13.7%
ROIC N/A
ROA(3y)1.47%
ROA(5y)N/A
ROE(3y)1.54%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ANZU Yearly ROA, ROE, ROICANZU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 1 2 3 4

1.3 Margins

ANZU does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ANZU Yearly Profit, Operating, Gross MarginsANZU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

1

2. Health

2.1 Basic Checks

ANZU has about the same amout of shares outstanding than it did 1 year ago.
ANZU has a worse debt/assets ratio than last year.
ANZU Yearly Shares OutstandingANZU Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 10M 20M 30M 40M 50M
ANZU Yearly Total Debt VS Total AssetsANZU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of 1.70, we must say that ANZU is in the distress zone and has some risk of bankruptcy.
ANZU has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 1.7
ROIC/WACCN/A
WACCN/A
ANZU Yearly LT Debt VS Equity VS FCFANZU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 0.04 indicates that ANZU may have some problems paying its short term obligations.
A Quick Ratio of 0.04 indicates that ANZU may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
ANZU Yearly Current Assets VS Current LiabilitesANZU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for ANZU have decreased strongly by -96.77% in the last year.
EPS 1Y (TTM)-96.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-230.97%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ANZU is valuated quite expensively with a Price/Earnings ratio of 701.50.
When comparing the Price/Earnings ratio of ANZU to the average of the S&P500 Index (28.18), we can say ANZU is valued expensively.
Industry RankSector Rank
PE 701.5
Fwd PE N/A
ANZU Price Earnings VS Forward Price EarningsANZU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ANZU Per share dataANZU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ANZU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ANZU SPECIAL ACQUISITION -A

NASDAQ:ANZU (9/29/2023, 8:17:40 PM)

After market: 7.02 +0 (+0.07%)

7.015

+1.38 (+24.38%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.33%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap104.80M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 701.5
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.4
P/tB 4.4
EV/EBITDA N/A
EPS(TTM)0.01
EY0.14%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS0
BVpS1.59
TBVpS1.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.24%
ROE 13.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.47%
ROA(5y)N/A
ROE(3y)1.54%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z 1.7
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-230.97%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18%
OCF growth 3YN/A
OCF growth 5YN/A